Markets:

Overview

News

Currencies

International

Treasuries

Health Catalyst, Inc - Common stock (NQ:HCAT)

1.770 +0.020 (+1.14%)

Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Health Catalyst, Inc - Common stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

What To Expect From Samsara’s (IOT) Q3 Earnings

December 04, 2024

Internet of Things company Samsara (NYSE:IOT) will be announcing earnings results tomorrow after market hours. Here’s what to look for.

Via StockStory

Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 26, 2024

Via Benzinga

The Latest Analyst Ratings For Health Catalyst ↗

November 13, 2024

Via Benzinga

Health Catalyst (NASDAQ:HCAT) Posts Q3 Sales In Line With Estimates

November 06, 2024

Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 3.5% year on year to $76.35 million. The company expects next quarter’s...

Via StockStory

Health Catalyst (HCAT) To Report Earnings Tomorrow: Here Is What To Expect

November 05, 2024

Healthcare software provider Health Catalyst (NASDAQ:HCAT) will be reporting earnings tomorrow afternoon. Here’s what to look for.

Via StockStory

What Analysts Are Saying About Health Catalyst Stock ↗

October 08, 2024

Via Benzinga

Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts ↗

September 20, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts ↗

August 26, 2024

Via Benzinga

The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts ↗

August 09, 2024

Via Benzinga

3 Overlooked Telehealth Stocks Poised for a Comeback ↗

July 16, 2024

Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.

Via InvestorPlace

A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts ↗

July 09, 2024

Via Benzinga

Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

June 06, 2024

Via Benzinga

Peeling Back The Layers: Exploring Health Catalyst Through Analyst Insights ↗

May 21, 2024

Via Benzinga

HCAT Stock Earnings: Health Catalyst Beats EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

HCAT stock results show that Health Catalyst beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

What 7 Analyst Ratings Have To Say About Health Catalyst ↗

April 10, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Health Catalyst ↗

February 23, 2024

Via Benzinga

Demystifying Health Catalyst: Insights From 7 Analyst Reviews ↗

January 26, 2024

Via Benzinga

Deep Dive Into Health Catalyst Stock: Analyst Perspectives (6 Ratings) ↗

January 03, 2024

Via Benzinga

SMART Global Reports Q2 Results, Joins Health Catalyst And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

April 10, 2024

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining by around 0.1% on Wednesday.

Via Benzinga

Expert Ratings for Health Catalyst ↗

December 13, 2023

Via Benzinga

D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

December 13, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday ↗

November 13, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Where Health Catalyst Stands With Analysts ↗

November 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 25, 2023

Via Benzinga

Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst ↗

October 16, 2023

Alignment Healthcare Inc (NASDAQ: ALHC) announced that its California Medicare Advantage (MA) HMO – which represents roughly 89% of its MA membership – has maintained an overall 4 out of 5-star rating...

Via Benzinga

Veeva Systems Stock Scores Rising Relative Strength Rating ↗

August 17, 2023

The Relative Strength (RS) Rating for Veeva Systems stock climbed into a higher percentile Thursday, as it got a lift from 67 to 72.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023 ↗

August 01, 2023

Via Benzinga

Health Catalyst's Q1 Earnings: Analysts Diverge on Outlook as Company Faces Demand Headwinds and Revenue Outperformance ↗

May 10, 2023

Health Catalyst Inc (NASDAQ: HCAT) reported Q1 sales of $73.87 million, up 22% Y/Y, beating the consensus of $71.24 million<

Via Benzinga

Nasdaq, S&P 500 Higher As Bond Yields Retreat ↗

May 10, 2023

Investor sentiment is boosted today by a better-than-expected consumer price index (CPI) reading for April.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 ↗

May 10, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.